Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning.

Journal: eLife
PMID:

Abstract

Cardiometabolic diseases are an increasing global health burden. While socioeconomic, environmental, behavioural, and genetic risk factors have been identified, a better understanding of the underlying mechanisms is required to develop more effective interventions. Magnetic resonance imaging (MRI) has been used to assess organ health, but biobank-scale studies are still in their infancy. Using over 38,000 abdominal MRI scans in the UK Biobank, we used deep learning to quantify volume, fat, and iron in seven organs and tissues, and demonstrate that imaging-derived phenotypes reflect health status. We show that these traits have a substantial heritable component (8-44%) and identify 93 independent genome-wide significant associations, including four associations with liver traits that have not previously been reported. Our work demonstrates the tractability of deep learning to systematically quantify health parameters from high-throughput MRI across a range of organs and tissues, and use the largest-ever study of its kind to generate new insights into the genetic architecture of these traits.

Authors

  • Yi Liu
    Department of Interventional Therapy, Ningbo No. 2 Hospital, Ningbo, China.
  • Nicolas Basty
    Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
  • Brandon Whitcher
    Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
  • Jimmy D Bell
    Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
  • Elena P Sorokin
    Calico Life Sciences LLC, South San Francisco, United States.
  • Nick van Bruggen
    Calico Life Sciences LLC, South San Francisco, United States.
  • E Louise Thomas
    Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
  • Madeleine Cule
    Calico Life Sciences LLC, South San Francisco, United States.